Ovulation Test Market

Ovulation Test Market Outlook (2023 to 2033)

A newly published study by Fact.MR reveals that the global ovulation test market stands at US$ 2.51 billion in 2023. Worldwide demand for fertility monitors is predicted to increase at a CAGR of 4.1% and reach a market value of US$ 3.76 billion by the end of 2033.

Demand for LH surge detection kits is on the rise due to the increasing female population of reproductive age and growing gynecological practices. The age of women giving birth is shifting due to changing lifestyles, coupled with delayed motherhood and a stronger focus on careers. A preference for automated digital ovulation test kits is positively influencing market prospects.

• According to the OCED (Organization for Economic Co-operation and Development), the increasing inclination towards delayed pregnancy contributes to the higher age of women giving birth, currently 30 years or more.

Prominent Market Growth Drivers

• Increasing focus on healthcare for women is predicted to amplify the rate of ovulation test adoption in many countries.
• Investments in R&D activities by prominent players to minimize the price of menstrual cycle tracking kits are widening industry prospects.

Ovulation tracking apps are generally based on urine or saliva. They can be conducted in home care settings without any assistance or support from a healthcare professional. They can detect the presence as well as the amount of LH hormones that play a pivotal role for women attempting to conceive.

Fertility tracking devices are readily accessible at medical stores and offer convenience in approach. While no strict guidelines dictate the timing for test conduction, some health professionals recommend morning testing, although it's not obligatory.

• Sales of ovulation test kits in China are projected to rise at a CAGR of 6.9% and reach US$ 677 million by 2033-end.
• Worldwide demand for urine-based ovulation tests is predicted to increase at 4.4% CAGR and reach a value of US$ 2.21 billion by 2033.

Lack of predictive power of fertility monitors is predicted to obstruct expansion opportunities. Furthermore, a dearth of skilled personnel and a lack of well-developed healthcare infrastructure across developing economies are predicted to challenge market expansion. The high cost of these fertility testing products is also limiting business opportunities.

Report Attributes	Details
Ovulation Test Market Size (2022)	US$ 2.41 Billion
Estimated Market Value (2023)	US$ 2.51 Billion
Projected Market Value (2033)	US$ 3.76 Billion
Global Market Growth Rate (2023 to 2033)	4.1% CAGR
United States Market Value (2022)	US$ 648 Million
Sales of Urine-based Test Kits (2033)	US$ 2.21 Billion
Japan Market Growth Rate (2023 to 2033)	2.2% CAGR
Germany Market Growth Rate (2023 to 2033)	2.8% CAGR
Key Companies Profiled	Accuquik Test Kits Fairhaven Health LLC Church & Dwight Co., Inc. Fertility Focus Limited HiLin Life Products, Inc. Geratherm Medical AG Nectar Lifesciences Ltd. (NLL) SPD Swiss Precision Diagnostics GmbH Prestige Brands Holdings

Which Factors are Shaping the Future Prospects of Ovulation Test Kit Manufacturers?

“Simplicity of Setup and Ease of Use Associated with Ovulation Test Kits”

Currently, many challenges are encountered globally in maintaining a pregnancy. Factors such as aging, health concerns, and other situations can negatively affect ovulation. Therefore, comprehending a woman's ovulation period is highly crucial, and fertility-tracking devices play a significant role in facilitating this process. The simplicity of setup, ease of use, near-accurate results, and diverse attributes of hormone-based ovulation tests are projected to enhance their demand worldwide.

“Rising Awareness about Fertility Tests”

A growing emphasis on brand protection, coupled with heightened awareness about fertility testing practices, is positively influencing opportunities for suppliers. Anticipated traction for digital ovulation tests is also expected to expand the scope for industry participants.

What Drawbacks of Ovulation Test Kits are Working Against Manufacturers?

“Lack of Projected Predictive Power and Precision of Ovulation Predictor Kits”

Ovulation predictor kits at times lack the projected predictive power and precision, potentially impeding growth prospects. These kits solely identify the luteinizing hormone preceding ovulation and do not confirm it. Usage of fertility drugs may disrupt the kit's functionality. The kit's efficacy is limited for women over 40 years old or approaching menopause. In developing economies, the lack of healthcare infrastructure and skilled professionals is expected to pose challenges to opportunities.

“High Prices of Ovulation Testing Equipment”

The cost of ovulation test kits is comparatively higher than other similar equipment. Therefore, it becomes difficult for consumers to opt for these reproductive healthcare products.

What Initiatives are Start-ups Taking to Expand Their Market Reach?

“Emphasis on Developing Advanced Digital Ovulation Kits”

Emergence of digital ovulation test kits is expected to offer start-ups a foundation to establish their positions. Increasing healthcare expenditure, coupled with the beneficial effects of technology on lifeline curves, is projected to contribute to the demand for these novel digital test kits. Additionally, the ongoing shifts in healthcare regulations are also contributing positively to opportunities for new players.

Country-wise Insights

North America is predicted to hold a significant position in the global ovulation test industry owing to the rising adoption of various innovative technologies for fertility tracking. The Asia Pacific market is estimated to expand at a significant pace compared to others due to a rapid increase in the count of women experiencing lifestyle disorders, including PCOS (polycystic ovary syndrome). Asia Pacific is forecasted to account for 34% share of global market revenue by 2033, according to Fact.MR.

What are the Contributors to the Continued Dominance of the United States?

“High Awareness about Significance of Planned Pregnancies”

The United States market reached US$ 648 million in 2022. Rising adoption of ovulation test kits, combined with increasing awareness about planned pregnancies, is creating opportunities for stakeholders in the United States.

The escalating incidence of diverse fertility challenges and the rising usage of digital ovulation test kits are driving industry expansion. Efforts made by stakeholders are projected to enhance existing digital test kits, with a focus on developing new offerings for better outcomes and cost-effectiveness. Notably, several major players from the United States are forming partnerships and collaborations to expand their product portfolios.

For instance :

• Sugentech is a prominent manufacturer of digital test kits in South Korea. In 2022, the company established a partnership with the United States-based company, CGETC, Inc.

Why are Ovulation Test Kit Manufacturers Attracted to Germany and the United Kingdom?

“Rising Use of Ovulation Tracking Apps and Focus of Manufacturers on Product Advancements”

Demand for ovulation test kits in Germany is predicted to advance at a CAGR of 2.8% through 2033. The United Kingdom and Germany are predicted to work as prominent markets in the European region owing to the rising use of various types of ovulation-tracking apps for contraception. Furthermore, increasing efforts dedicated to product advancements are also anticipated to unveil fresh prospects in that regard.

Which Countries from Asia Pacific Will Account for High Ovulation Test Kit Sales?

“Increasing Investments in Development of Ovulation Test Kits in India and China”

Sales of ovulation test kits in the Chinese market are projected to rise at a 6.9% CAGR and reach US$ 677 million by 2033-end. India and China are prominent regional markets in Asia Pacific owing to a noteworthy increase in the population of women encountering lifestyle disorders. Growing investments/funding for the development of ovulation and fertility monitors are estimated to drive their demand.

Increasing cases of first-time pregnancies is one of the key aspects pushing sales of ovulation test kits in the abovementioned countries. The rising disposable income is leading to increased spending on healthcare-related products.

Category-wise Insights

Based on type, sales of urine-based ovulation test kits are forecasted to advance at a CAGR of 4.4% through 2033 due to their accuracy in detecting ovulation. Moreover, home care settings are estimated to contribute significantly to revenue streams because of their easy availability and user-friendly approach to fertility testing.

Why is Demand for Urine-based Ovulation Test Kits Rising?

“High Accuracy of Urine-based Ovulation Tests”

Global demand for urine-based fertility tracking devices is projected to advance at a 4.4% CAGR and reach US$ 2.21 billion by 2033-end. Urine-based ovulation tests are estimated to hold a leading share of the market in 2033.

The higher accuracy level of urine-based ovulation detection strips is contributing to their increased demand. In addition, urine-based ovulation calculators show the presence as well as the absence of HCG (human chorionic gonadotropin), which indicates pregnancy.

Which End User is Generating High Demand for Ovulation Test Kits?

“User-friendliness of Ovulation Test Kits Driving Sales in Home Care Settings”

Based on end user, the global market is classified into home care settings, hospitals, and clinics. Among these, home care settings are forecasted to account for a leading share of the market over the next 10 years because of the growing demand for different types of home testing devices. User-friendly approach, rising preference for result confidentiality, and easy availability of ovulation test kits are generating their demand in home care settings.

Key Market Players

Manufacturers of ovulation test kits are coming up with various strategies to reach their goals, including new developments, ensuring quality control of products, management of supply chain systems, and others. Industry players are spending on product launches, which are estimated to help strengthen their position.

For instance :

• bioMérieux, in June 2021, announced its distribution of some particular diagnostics in Europe. The product, REVEAL Rapid AST system, is predicted to strengthen its position in rapid testing kits.

Accuquik Test Kits, Fairhaven Health LLC, Church & Dwight Co., Inc., Fertility Focus Limited, HiLin Life Products, Inc., Geratherm Medical AG, Nectar Lifesciences Ltd. (NLL), SPD Swiss Precision Diagnostics GmbH, and Prestige Brands Holdings are key players in the ovulation test market.

Segmentation of Ovulation Test Industry Research

• By Type :

  • Urine-based
  • Saliva-based

• By End User :

  • Hospitals
  • Home Care Settings
  • Clinics

• By Region :

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa